Esophagogastric cancer: integration of targeted therapies into systemic chemotherapy. [electronic resource]
- Current cancer drug targets Jul 2011
- 681-7 p. digital
Publication Type: Journal Article; Review
1873-5576
10.2174/156800911796191006 doi
Angiogenesis Inhibitors--therapeutic use Antineoplastic Agents--therapeutic use Clinical Trials, Phase III as Topic ErbB Receptors--antagonists & inhibitors Esophageal Neoplasms--drug therapy Humans Molecular Targeted Therapy Receptor, ErbB-2--antagonists & inhibitors Stomach Neoplasms--drug therapy